These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17969224)

  • 1. Sustaining Treatment Costs: Who will Pay? Proceedings of a meeting, 27-29 November 2006, Washington, DC, USA.
    AIDS; 2007 Jul; 21 Suppl 4():S1-130. PubMed ID: 17969224
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustaining treatment costs: who will pay?
    Zewdie D; De Cock K; Piot P
    AIDS; 2007 Jul; 21 Suppl 4():S1-4. PubMed ID: 17620744
    [No Abstract]   [Full Text] [Related]  

  • 3. Global AIDS conference finds the issue is cash.
    Cullinan K
    Bull World Health Organ; 2002; 80(9):761-2. PubMed ID: 12378299
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiretroviral therapy in South Africa--can we do it?
    Bekker LG; Wood R
    S Afr Med J; 2002 Mar; 92(3):191-3. PubMed ID: 12040936
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV prevention and treatment in Africa.
    Laurence J
    AIDS Patient Care STDS; 2000 Aug; 14(8):399-400. PubMed ID: 10977967
    [No Abstract]   [Full Text] [Related]  

  • 6. Highly active antiretroviral therapy (HAART)--plus: next steps to enhance HAART in resource-limited areas?
    Flanigan TP; Wools-Kaloustain K; Harwell J; Cu-Uvin S; Kimaiyo S; Carter EJ
    Clin Infect Dis; 2007 Dec; 45(11):1499-501. PubMed ID: 17990234
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drugs for antiretroviral therapy. The costs of HAART].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiretroviral treatment of HIV infections in poor countries].
    Eskesen AN
    Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3255-7. PubMed ID: 14714026
    [No Abstract]   [Full Text] [Related]  

  • 9. Providing antiretroviral therapy for HIV infection.
    Steinbrook R
    N Engl J Med; 2001 Mar; 344(11):844-6. PubMed ID: 11248164
    [No Abstract]   [Full Text] [Related]  

  • 10. Avoid a different standard of care when applying results of Development of Antiretroviral Therapy in Africa (DART) study.
    Sayana S; Manchanda R; Khanlou H; Saavedra J; Reis P; Weinstein M
    J Acquir Immune Defic Syndr; 2010 Jan; 53(1):153-4. PubMed ID: 20035167
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of HIV disease in the third millennium: clinical and related economic issues.
    Manfredi R
    Int J Antimicrob Agents; 2002 Mar; 19(3):251-3. PubMed ID: 11932152
    [No Abstract]   [Full Text] [Related]  

  • 12. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

  • 13. Simplifying HIV therapeutics, and the global treatment of AIDS.
    Laurence J
    AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost of antiretroviral treatment for HIV patients in two centres of North India.
    Sharma A; Prinja S; Sharma A; Gupta A; Arora SK
    Int J STD AIDS; 2019 Jul; 30(8):769-778. PubMed ID: 31081489
    [No Abstract]   [Full Text] [Related]  

  • 15. The (political) economics of antiretroviral treatment in developing countries.
    Nattrass NJ
    Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal access to antiretroviral therapy: when, not if.
    Carpenter CC
    Clin Infect Dis; 2006 Jan; 42(2):260-1. PubMed ID: 16355338
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of mother-to-child transmission of HIV infection.
    Luzuriaga K; Sullivan JL
    Clin Infect Dis; 2005 Feb; 40(3):466-7. PubMed ID: 15668872
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiretroviral therapy where resources are limited.
    Reynolds SJ; Bartlett JG; Quinn TC; Beyrer C; Bollinger RC
    N Engl J Med; 2003 May; 348(18):1806-9. PubMed ID: 12724489
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?
    Lawn SD; Myer L; Wood R
    Clin Infect Dis; 2005 Dec; 41(11):1683-4; author reply 1684. PubMed ID: 16267745
    [No Abstract]   [Full Text] [Related]  

  • 20. The ethics of expanding access to cheaper, less effective treatments.
    Persad GC; Emanuel EJ
    Lancet; 2016 Aug; 388(10047):932-4. PubMed ID: 27108231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.